These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27974852)

  • 1. Four microRNAs Signature for Survival Prognosis in Colon Cancer using TCGA Data.
    Xu J; Zhao J; Zhang R
    Sci Rep; 2016 Dec; 6():38306. PubMed ID: 27974852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M; Kong X; Wang H; Huang G; Ye C; He Z
    Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer.
    Wang XJ; Zeng B; Lin S; Chen M; Chi P
    Ann Clin Lab Sci; 2019 Nov; 49(6):730-739. PubMed ID: 31882423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of 5-microRNA based signature in T2-T3N0 colon cancer.
    Bobowicz M; Skrzypski M; Czapiewski P; Marczyk M; Maciejewska A; Jankowski M; Szulgo-Paczkowska A; Zegarski W; Pawłowski R; Polańska J; Biernat W; Jaśkiewicz J; Jassem J
    Clin Exp Metastasis; 2016 Dec; 33(8):765-773. PubMed ID: 27485175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying a new microRNA signature as a prognostic biomarker in colon cancer.
    Lv Y; Duanmu J; Fu X; Li T; Jiang Q
    PLoS One; 2020; 15(2):e0228575. PubMed ID: 32049961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific microRNAs as novel biomarkers for combination chemotherapy resistance detection of colon adenocarcinoma.
    Hu J; Xu Y; Cai S
    Eur J Med Res; 2015 Dec; 20():95. PubMed ID: 26626874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying High-Risk Stage II Colon Cancer Patients: A Three-MicroRNA-Based Score as a Prognostic Biomarker.
    Caritg O; Navarro A; Moreno I; Martínez-Rodenas F; Cordeiro A; Muñoz C; Ruiz-Martinez M; Santasusagna S; Castellano JJ; Monzó M
    Clin Colorectal Cancer; 2016 Dec; 15(4):e175-e182. PubMed ID: 27247088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A microRNA expression signature as a predictor of survival for colon adenocarcinoma.
    Xu M; Kuang Y; Wang M; Han X; Yang Q
    Neoplasma; 2017; 64(1):56-64. PubMed ID: 27881005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
    Zhang J; Chong CC; Chen GG; Lai PB
    PLoS One; 2015; 10(6):e0128628. PubMed ID: 26046780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis.
    Xiong J; Xiong K; Bing Z
    Cancer Biomark; 2018 Feb; 21(3):535-546. PubMed ID: 29226853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
    Wei HT; Guo EN; Liao XW; Chen LS; Wang JL; Ni M; Liang C
    Oncol Rep; 2018 Oct; 40(4):1947-1958. PubMed ID: 30066920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma.
    Gao X; Wu Y; Yu W; Li H
    Oncotarget; 2016 Dec; 7(49):81670-81679. PubMed ID: 27835574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
    Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
    Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
    Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas.
    Qian Z; Li Y; Fan X; Zhang C; Wang Y; Jiang T; Liu X
    J Neurooncol; 2018 Mar; 137(1):127-137. PubMed ID: 29204839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel microRNA signature predicts survival in stomach adenocarcinoma.
    Ding B; Gao X; Li H; Liu L; Hao X
    Oncotarget; 2017 Apr; 8(17):28144-28153. PubMed ID: 28423653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients.
    Kleivi Sahlberg K; Bottai G; Naume B; Burwinkel B; Calin GA; Børresen-Dale AL; Santarpia L
    Clin Cancer Res; 2015 Mar; 21(5):1207-14. PubMed ID: 25547678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A four-microRNA classifier as a novel prognostic marker for tumor recurrence in stage II colon cancer.
    Jacob H; Stanisavljevic L; Storli KE; Hestetun KE; Dahl O; Myklebust MP
    Sci Rep; 2018 Apr; 8(1):6157. PubMed ID: 29670141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer.
    Gong C; Tan W; Chen K; You N; Zhu S; Liang G; Xie X; Li Q; Zeng Y; Ouyang N; Li Z; Zeng M; Zhuang S; Lau WY; Liu Q; Yin D; Wang X; Su F; Song E
    EBioMedicine; 2016 Sep; 11():199-209. PubMed ID: 27566954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a six microRNA signature as a novel potential prognostic biomarker in patients with head and neck squamous cell carcinoma.
    Shi H; Chen J; Li Y; Li G; Zhong R; Du D; Meng R; Kong W; Lu M
    Oncotarget; 2016 Apr; 7(16):21579-90. PubMed ID: 26933913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.